Overall, the data suggest that celastrol suppresses HCC development in AKT/c-Met HCC by arresting cell proliferation, and the effects could be involved in down-regulation of AFP mRNA translation and protein synthesis. Here, AKT1 is linked to hepatocellular carcinoma.